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7, 15 and 30 th days of treatment decreased respectively 151, 188, 131 %. The level of general lipids in the composition of blood decreased by 44.5 % against 96.9 % in not untreated series. The level of cholesterol decreased to 32.2 % (in control 217.7 %). The contents triglycerides decreased to 42.2 % against 110 % in not untreated series. The level of hdl of serum blood increased by 61.5 % in comparison with control series. The level of MdA t serum blood rabbits in the results of conducted course of treatment by "Novobet" decreased to 35.9 % in comparison with not untreated series.
"Arfazetin" defendedanimals from death with alloksangidrat diabetes only by 45.7 %. The sugar lowering, lipid-lowering and antioxidant effects of "Arfazetin" were weaker in average from 11 to 41 % than in identical dose of "Novobet."
Conclusion. The manifestation of active hypoglycemic, hypolipidemic and antioxidant actions of "Novobet" is connected with rich content of polyphenols, flavonoids, macro-and microelements, and a number of other bAS included in the composition of collection of medicinal plants.
Conclusions. "Novobet" shows active hypoglycemic, lipidlowering and antioxidant effects. The data obtained allow to recommend "Novobet" for therapy of prediabetes of different genesis of type 2 diabetes of light and average degrees severity and as a supporting remedy for therapy of vascular complications type 1 and type 2 diabetes.
THE SAFETY QUESTIONS OF APPLICATION OF MEDICINAL PLANTS
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Absence of international unification experimental and clinical information, which are characterising the toxic effect of biological active substance, leads to application of prohibited medicinal plants (Aristolochia, Piper methysticum, Sassafras и etc.) in some countries in consequence of difficult side effects. Especially important is evaluation of safety of medicinal plants which causes life threatening side effects or if carcinogenic, hepatotoxic effects experimentally established. Acorus calamus, Aristolochia franchi, Tussilago farfara, Symphytum officinale, Centella asiatica -are medicinal plants with potential carcinogenic effect. however, risk assessment criteria for these plants are not developed. Maximal allowable concentrations is established only for some toxic substances. The introduction of maximal allowable concentrations is an important action in prevention of potential toxic effects of selected medicinal plants. for safety evaluating of medicinal plants is necessary to take into consideration the development of delayed side effects, which are developed during some weeks or months. Such side effects are characteristic of medicinal plants, with hormonal activity, menstrual cycle or blood coagulation system. The commission E (Germany) has considered data for 299 medicinal plants:
